News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clarus Therapeutics To Present Phase 3 Data For REXTORO® At ICE/ENDO 2014


5/28/2014 9:14:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NORTHBROOK, Ill., May 28, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral testosterone (T) replacement product, today announced the presentation of two posters at the 16th International Congress of Endocrinology and The Endocrine Society's 96th Annual Meeting and Expo, June 21-24 in Chicago. This will be the first time in almost 20 years the two groups will unite to present ICE/ENDO 2014, with over 10,000 endocrinologists and hormone researchers from around the world expected to attend.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES